AzTrials
AzTrials

Mental HandicapSABNCT02818374

The Oral Accessibility Spatula (Spatule SAB)

A study testing oral accessibility spatula (SAB) in people with Mental Handicap, run by Centre Hospitalier Régional Metz-Thionville at 7 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the efficiency and the safe use of a new medical device to improve the oral accessibility of disabled people during the oral-dental examination. Read more about this study

Who is it for?
Any age
Conditions the study is for
Mental Handicap
What is being tested?
oral accessibility spatula (SAB)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
7 sitesFrance
Study dates
Mar 2016to Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Mental disability patient with behavioural troubles known or noticed during the approach of hand for dental examination
  • Venham Scale score of 2 and higher, meaning opposing, after an approach toward the oral cavity
  • Information of the responsible person for the patient, if necessary, and followed by the dated signed informed consent

Who cannot join

  • pregnant or nursing woman
  • lack of social security
  • people under guardianship

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

France7 sites
  • CHU Dijon

    Dijon

  • Centre Hospitalier Emile Durkheim

    Épinal, 88000

  • Clinique Saint Francois

    Haguenau

  • CHR Metz-Thionville- Mercy Hospital

    Metz, 57085

  • CHRU Nancy

    Nancy, 54000

  • CHRU Strasbourg

    Strasbourg, 67000

  • CHR METZ THIONVILLE- Bel-Air Hospital

    Thionville, 57126

Other trials in France

About this study

Official title: Evaluation of the Efficacy and Safety of Use of an Innovative Medical Device for Improving Oral Accessibility in People With Disabilities, Presenting Behavioral Disorders: The Oral Accessibility Spatula (Spatule SAB)

The purpose of this study is to evaluate the efficiency and the safe use of a new medical device to improve the oral accessibility of disabled people during the oral-dental examination.

Read the detailed description

The oral examination of people with behavioural handicap seems to be difficult. Those patients react with defensive reflexes which limit spontaneously the amplitude of their oral cavity or prevent them to keep open their mouth for a sufficient time to process the examination. This difficulty can be caused by various reasons: cerebral motor disability, behavioral troubles or mental disability, and it affects people of all ages.

The current methods keeping open the mouth like wedges are often unsuitable for those patients. Moreover, no other device exists or is described even in literature. An innovative medical device has to be developed, in order to offer to disabled patients and the users or dentists a comfort during the oral-dental examination.

The oral accessibility spatula, made out polypropylene plastic, is designed into two parts :

  • a handle to hold the spatula by the user
  • a thin plastic surface introduced into the mouth, which is dull with a round edge and has holes on the sides to lock the spatula between the upper and lower teeth.

Primary objective :

To evaluate the buccal access during a first oral-dental examination without and then with the oral accessibility spatula (SAB).

Secondary objective :

To evaluate the safe use of the SAB To evaluate the tolerance of the exam without, and then with the SAB

Primary endpoint :

Visibility and dental examination of incisor-canine sectors, premolars and molars using a probe, assessed by an oral accessibility score determined based on intra oral accessible areas with and without oral accessibility Spatula device

Secondary endpoints :

The safety of the spatula will be assessed by analyzing the reported adverse effects and their relative frequency The dental exam tolerance evaluation; with and without Oral Accessibility .Spatula

Methodology :

Multi-center interventional prospective study, open-label Only one medical check per patient

Procedures :

Any patient with a behavioral handicap, and who consults with dentist for a preventive check-up or a oral-dental curative act, is examined by an inclusion operator who checks the inclusion or non-inclusion criteria, and especially the behavior with Venham Scale (only patients with a score of 2 and higher, meaning opposing, after an approach toward the oral cavity are included).

The oral accessibility score of each eligible patient is performed twice, without the SAB first, and then with the SAB.

The incidents and/or potential injuries are reported from a standardized grid. Venham scale score is measured a second time during the oral-dental examination without or with the spatula.

Patients number :

Without the SAB, the rate of patients with an oral accessibility score of at least level 8 is 20%.

The protocol forecasts hypothetically a 20% highering of this rate after the use of SAB (so 40% of patients with a score of 8 and higher). With a total staff of 140 patients, this hypothesis is validated with an α risk set at 5% and a statistical power at 90%. 200 patients are expected in order to take into account a potential center effect and a potential investigator effect, and a study output rate of 10%.

Trial Time :

Only one medical check per patient, so the total duration goes with the inclusion period of 18 months.

Expected study start : first semester of 2016 End of inclusion : second semester of 2017 End of study : second semester of 2017

Statistical Analysis :

The major analysis will be the comparison of the oral accessibility scores during the examination with or without the SAB. Each patient will be his own control, and the examinations always will be performed without the SAB in first, and secondly with the SAB, by the same dental surgeon.

Expected Benefits :

The expected result is the proof of a best examination quality with no risk for the patient. The major prospect is the availability of the SAB to dental surgeons to improve the therapeutic indications and the quality of examinations, then to parents, carers and caregivers, in order to make possible and easier the application of a oral-dental health suitable for handicapped or disabled people.

So, the expected benefits are :

  • early diagnostic of the oral-dental diseases
  • improved efficiency of the tooth care
  • reduction of the use of general anesthesia for oral examinations
  • help for tooth washing in order to improve significantly the oral-dental healthy level
  • improved prevention by the availability of the spatula to parents, carers and physicians.

Quality Assurance Plan :

Data will be recorded in a Paper Case Report from medical records. The patients will undergo only one medical examination for the study. No follow-up is expected.

Conditions
Mental Handicap
Being tested
oral accessibility spatula (SAB)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • oral accessibility spatula (SAB)Device

Study groups in NCT02818374
Study groupRoleWhat they receive
Disabled People with behavioral troubleExperimentalNot described
Receives: Device: oral accessibility spatula (SAB)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visibility and dental examination of incisor-canine sectors, premolars and molars using a probe, assessed by an oral accessibility score determined based on intra oral accessible areas with and without oral accessibility Spatula device

    score of 0 = no access to 12 = total accessibility

    Measured: 1 day

Secondary outcomes (2)
  1. The safety of the spatula will be assessed by analyzing the reported adverse effects and their relative frequency

    Measured: 1 day

  2. The dental exam tolerance evaluation with and without Oral Accessibility Spatula

    using Venham behaviour scale

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2016 (estimated)
  2. Study startMar 2016
  3. Primary completionDec 2018
  4. Study completionMar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02818374
Sponsor's protocol ID
2014-02-CHRMT
Acronym
SAB
Status last verified
Feb 2019
First submitted
30 Mar 2016
Last updated
24 Jun 2026
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Mogenot M, Hein-Halbgewachs L, Goetz C, Ouamara N, Droz-Desprez D, Strazielle C, Albecker S, Mengus B, Strub M, Maniere MC, Richardin P, Wang S, Piga G, Dalstein A, Anastasio D. Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in special-needs patients: A multicentric clinical trial. PLoS One. 2020 Sep 28;15(9):e0239898. doi: 10.1371/journal.pone.0239898. eCollection 2020.

    PubMed 32986784

Questions about this trial

What is this clinical trial studying?

A study testing oral accessibility spatula (SAB) in people with Mental Handicap, run by Centre Hospitalier Régional Metz-Thionville at 7 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visibility and dental examination of incisor-canine sectors, premolars and molars using a probe, assessed by an oral accessibility score determined based on intra oral accessible areas with and without oral accessibility Spatula device (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02818374, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in